# EVEROLIMUS
> **ANDA210130** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2019-04-19
## Drug
- **FDA Application Number:** ANDA210130
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EVEROLIMUS
- **Generic name:** Everolimus
- **Active ingredients:** EVEROLIMUS
- **Dosage form:** TABLET, FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** MYLAN
- **First approval:** 2019-04-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210130)
---
*MORVS · CC0 1.0*